Statins and muscle pain

被引:27
作者
Pergolizzi, Joseph V., Jr. [1 ]
Coluzzi, Flaminia [2 ]
Colucci, Robert D. [1 ,3 ]
Olsson, Hanna [4 ]
LeQuang, Jo Ann [1 ]
Al-Saadi, Jonathan [4 ]
Magnusson, Peter [4 ,5 ]
机构
[1] NEMA Res Inc, Naples, FL USA
[2] Sapienza Univ Rome, Unit Anaesthesia Intens Care & Pain Med, Dept Med & Surg Sci & Biotechnol, Rome, Italy
[3] Colucci & Associates LLC, Newtown, CT USA
[4] Reg Gavleborg Uppsala Univ, Ctr Res & Dev, Gavle, Sweden
[5] Karolinska Inst, Inst Med, Cardiol Res Unit, Stockholm, Sweden
关键词
Adverse events; cardiovascular disease; statin; muscle pain; myalgia; side effects; DRUG-DRUG INTERACTIONS; VITAMIN-D DEFICIENCY; CREATINE-KINASE; INDUCED MYOPATHY; RISK-FACTORS; CHOLESTEROL-METABOLISM; RANDOMIZED-TRIAL; COENZYME Q(10); POSITION PAPER; NERVE INJURY;
D O I
10.1080/17512433.2020.1734451
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are often reported from patients on statins. Muscle symptoms are frequently reported as adverse events associated with statin therapy. Areas covered: In the present narrative review, statin-associated muscle pain is discussed. It elucidates potential mechanisms and possible targets for management. Expert opinion: In general, the evidence in support of muscle pain caused by statins is in some cases equivocal and not particularly strong. Reported symptoms are difficult to quantify. Rarely is it possible to establish a causal link between statins and muscle pain. In randomized controlled trials, statins are well tolerated, and muscle-pain related side-effects is similar to placebo. There are also nocebo effects of statins. Exchange of statin may be beneficial although all statins have been associated with muscle pain. In some patients reduction of dose is worth trying, especially in primary prevention Although the benefits of statins outweigh potential risks in the vast majority of cases, careful clinical judgment may be necessary in certain cases to manage potential side effects on an individual basis.
引用
收藏
页码:299 / 310
页数:12
相关论文
共 127 条
[1]   Coenzyme Q biosynthesis in health and disease [J].
Acosta, Manuel Jesus ;
Fonseca, Luis Vazquez ;
Desbats, Maria Andrea ;
Cerqua, Cristina ;
Zordan, Roberta ;
Trevisson, Eva ;
Salviati, Leonardo .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2016, 1857 (08) :1079-1085
[2]   An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity [J].
Alzghari, Saeed K. .
CUREUS, 2018, 10 (04)
[3]  
[Anonymous], 2011, REDUCE MAXIMUM DOSE
[4]  
Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519
[5]   The role of mitochondria in statin-induced myopathy [J].
Apostolopoulou, Maria ;
Corsini, Alberto ;
Roden, Michael .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (07) :745-754
[6]   Statins and the neuromuscular system: a neurologist's perspective [J].
Argov, Z. .
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (01) :31-36
[7]   Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial [J].
Armitage, Jane ;
Bowman, Louise ;
Wallendszus, Karl ;
Bulbulia, Richard ;
Rahimi, Kazem ;
Haynes, Richard ;
Parish, Sarah ;
Peto, Richard ;
Collins, Rory ;
Meade, T. ;
Sleight, P. ;
Collins, R. ;
Armitage, J. ;
Bowman, L. ;
Parish, S. ;
Peto, R. ;
Barton, J. ;
Bray, C. ;
Wincott, E. ;
Dayanandan, R. ;
Clarke, R. ;
Graham, I. ;
Simpson, D. ;
Warlow, C. ;
Wilken, D. ;
Tobert, J. ;
Mushner, T. ;
Doll, R. ;
Wilhelmsen, L. ;
Fox, K. ;
Hill, C. ;
Sandercock, P. ;
Webster, J. ;
Henderson, J. ;
Nixon, A. ;
Lackie, S. ;
Thompson, J. ;
Brown, M. ;
Blackwood, S. ;
Morgan, M. ;
Rhoden, W. ;
Saeed, B. ;
Houghton, M. ;
Nicholson, A. ;
Simpson, C. ;
Hoburn, B. ;
Cooper, I. ;
Gallivan, A. ;
Pickerell, E. ;
Hancock, J. .
LANCET, 2010, 376 (9753) :1658-1669
[8]  
Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010]
[9]   Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance [J].
Backes, James M. ;
Venero, Carmelo V. ;
Gibson, Cheryl A. ;
Ruisinger, Janelle F. ;
Howard, Patricia A. ;
Thompson, Paul D. ;
Moriarty, Patrick M. .
ANNALS OF PHARMACOTHERAPY, 2008, 42 (03) :341-346
[10]   Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance [J].
Ballard, Kevin D. ;
Parker, Beth A. ;
Capizzi, Jeffrey A. ;
Grimaldi, Adam S. ;
Clarkson, Priscilla M. ;
Cole, Stephanie M. ;
Keadle, Justin ;
Chipkin, Stuart ;
Pescatello, Linda S. ;
Simpson, Kathleen ;
White, C. Michael ;
Thompson, Paul D. .
ATHEROSCLEROSIS, 2013, 230 (01) :121-124